Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2017
Price : $35 *
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 31 Mar 2017 Results published in the Journal of Clinical Endocrinology and Metabolism
- 31 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Jul 2014 New source identified and integrated the European Clinical Trials Database record.